Front. Oncol. Frontiers in Oncology Front. Oncol. 2234-943X Frontiers Media S.A. 10.3389/fonc.2024.1475049 Oncology Retraction Retraction: LOXL2 upregulation in gliomas drives tumorigenicity by activating autophagy to promote TMZ resistance and trigger EMT Frontiers Editorial Office *

Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland

*Correspondence: Frontiers Editorial Office, research.integrity@frontiersin.org

27 08 2024 2024 14 1475049 02 08 2024 13 08 2024 Copyright © 2024 Frontiers Editorial Office 2024 Frontiers Editorial Office

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

 A Retraction of the Original Research Article LOXL2 upregulation in gliomas drives tumorigenicity by activating autophagy to promote TMZ resistance and trigger EMT By Zhang Q, Yang L, Guan G, Cheng P, Cheng W and Wu A (2020). Front. Oncol. 10:569584. doi: 10.3389/fonc.2020.569584 section-in-acceptance Neuro-Oncology and Neurosurgical Oncology

The journal retracts the 29th October 2020 article cited above.

Following publication, concerns were raised regarding the integrity of the images in the published figures. The authors requested retraction due to the image integrity concerns, which was then investigated and conducted in accordance with Frontiers’ policies.

This retraction was approved by the Chief Executive Editor of Frontiers. The authors agreed with the retraction.